Exane Derivatives Makes New $60,000 Investment in Constellium SE (NYSE:CSTM)


Exane Derivatives bought a new position in Constellium SE (NYSE:CSTM – Get Rating ) during the first quarter, Holdings Channel reports. The institutional investor purchased 3,359 shares of the industrial products company’s stock, valued at approximately $60,000.

Other institutional investors also recently added to or reduced their stakes in the company. Edmond DE Rothschild Holding SA purchased a new stake in Constellium in the fourth quarter valued at $76,000. Envestnet Asset Management Inc. boosted its holdings in Constellium by 29.0% in the fourth quarter. Envestnet Asset Management Inc. now owns 14,592 shares of the industrial products company’s stock valued at $261,000 after purchasing an additional 3,278 shares in the last quarter. Parallax Volatility Advisers LP purchased a new stake in Constellium in the fourth quarter valued at $306,000. Qube Research & Technologies Ltd purchased a new stake in Constellium in the fourth quarter valued at $361,000. Finally, ProShare Advisors LLC boosted its holdings in Constellium by 72.3% in the fourth quarter. ProShare Advisors LLC now owns 27,176 shares of the industrial products company’s stock worth $486,000 after purchasing an additional 11,402 shares in the last quarter. 90.54% of the shares are currently owned by institutional investors and hedge funds.

A number of research analysts have recently issued reports on CSTM shares. Deutsche Bank Aktiengesellschaft upped their price objective on Constellium from $22.00 to $25.00 in a report on Thursday, April 28th. StockNews.com raised Constellium from a “hold” rating to a “buy” rating in a report on Thursday, April 28th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $24.17.

Shares of Constellium stock opened at $12.92 on Friday. The stock has a market cap of $1.81 billion, a PE ratio of 4.22 and a beta of 1.99. The company has a debt-to-equity ratio of 3.44, a quick ratio of 0.58, and a current ratio of 1.22. Constellium SE has a one year low of $11.79 and a one year high of $21.59. The stock has a fifty day moving average of $15.17 and a 200 day moving average of $17.00.

Constellium (NYSE:CSTM – Get Rating ) last posted its quarterly earnings data on Wednesday, April 27th. The industrial products company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.74. The company had revenue of $1.98 billion during the quarter, compared to analysts’ expectations of $1.88 billion. Constellium had a return on equity of 100.02% and a net margin of 5.76%. Constellium’s revenue for the quarter was up 47.6% compared to the same quarter last year. During the same quarter a year ago, the business earned $0.15 per share. As a group, sell-side analysts forecast that Constellium SE will post 1.56 EPS for the current fiscal year.

About Constellium (Get rating)

Constellium SE, together with its subsidiaries, engages in the design, manufacture and sale of specialty rolled and extruded aluminum products for the packaging, aerospace and automotive markets. The company operates through three segments: Automotive Packaging and Rolled Products, Aerospace and Transportation, and Automotive Structures and Industry.

Read more

Want to see what other hedge funds are holding CSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Constellium SE (NYSE:CSTM – Get Rating ) .

Institutional Ownership by Quarter for Constellium (NYSE:CSTM)



Get Constellium Daily news and reviews – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Constellium and related companies with MarketBeat.com ‘s FREE daily email newsletter.

Leave a Comment

Your email address will not be published.